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This paper evaluated the diagnostic power of electrocochleography (ECochG) in detecting M´ eni` ere’s disease (MD) as compared
withtwosubjectiveassessmentmethods,includingtheclinicalguidelinesprovidedbytheAmericanAcademyofOtolaryngology—
Head and Neck Surgery Committee on Hearing Equilibrium and the Gibson score. A retrospective study of 250 suspected MD
cases was conducted. The agreement between the three assessment methods was found to be relatively high, with a total reliability
being higher than 70%. Participants who tested “positive” with ECochG exhibited a higher occurrence rate of asymmetric hearing
threshold as well as the four MD symptoms, namely, vertigo, hearing loss, tinnitus, and aural fullness. The “positive” ECochG
groupalsoshowedahighcorrelationbetweentheECochGmeasuresinresponsetostimuliatadjacentfrequencyranges,suggesting
that the interfrequency ECochG correspondence may be sensitive to the presence of endolymphatic hydrops and thus may serve as
a useful diagnostic marker for MD.
1.Introduction
M´ eni` ere’s disease is an idiopathic inner-ear disorder [1, 2].
It is characterised by episodes of vertigo, roaring tinnitus,
ﬂuctuating sensorineural hearing loss, and a sense of aural
fullness in the aﬀected ear, with a combination of these signs
or symptoms ﬂuctuating over months and years [3]. The
diagnosis of MD is normally made using the clinical guide-
lines set by the American Academy of Otolaryngology—
Head and Neck Surgery Committee on Hearing and Equi-
librium (AAO-HNS CHE) based on a selection of signs
and symptoms [4]. The diagnosis of MD can also be
assisted with measurements such as the Gibson score [5],
electrocochleography (ECochG), and, more recently, mag-
netic resonance imaging [6, 7]. However, as the histological
information and thus the conﬁrmation of an MD diagnosis
can only be obtained through postmortem biopsies [8],
the administration of appropriate clinical diagnostic tools
and treatment remains a challenging task. To facilitate the
application of an instrumental, objective, and thus possibly
more reliable approach in the diagnosis of an MD, this study
investigated the agreement on the diagnosis of MD between
ECochG and the two commonly used subjective methods,
the AAO-HNS CHE guidelines and the Gibson score.
The AAO-HNS CHE guidelines for the diagnosis of MD
were ﬁrst established in 1972 and later revised in 1985
and 1995. The most recent version of the AAO-HNS CHE
guidelines, as shown in Table 1, classiﬁes the diagnosis of
MD into four levels: “possible,” “probable,” “deﬁnite,” and
“certain” [4]. It has been shown in a review study that 79.9%
of the papers reviewed reported the use of the AAO-HNS
CHE criteria; however, only 50% of those publications used
the AAO-HNS CHE criteria correctly to diagnose MD [9].
As data may be less comparable between studies if the AAO-
HNS CHE criteria are not strictly adhered to [10], there are
concerns about the accuracy of the diagnosis made based
on the AAO-HNS CHE criteria for some patients. Questions
have been also raised regarding the limitations of the 1995
AAO-HNS CHE guidelines in its scope of symptom investi-
gation, such as the length of vertigo attacks and the severity2 International Journal of Otolaryngology
Table 1: The 1995 AAO-HNS criteria for the diagnosis of M´ eni` ere’s disease (adapted from [4, page 182]).
Category Criteria
“Possible”
(i) Episodic vertigo of the M´ eni` ere type (i.e., spontaneous rotation vertigo lasting for 20 minutes or greater, often
accompanied by disequilibrium which may last for days as well as nausea and rotatory nystagmus)
(ii) Without documented hearing loss or with sensorineural hearing loss, ﬂuctuating or ﬁxed, with disequilibrium but
without deﬁnitive episodes
(iii) Other causes of vertigo excluded
“Probable”
(i) One deﬁnitive episode of vertigo
(ii) Audiometrically documented hearing loss on at least one occasion
(iii) Tinnitus or aural fullness in the treated ear
(iv) Other causes excluded
“Deﬁnite”
(i) Two or more deﬁnitive spontaneous episodes of vertigo lasting for 20 minutes or longer
(ii) Audiometrically documented hearing loss on at least one occasion
(iii) Tinnitus or aural fullness in the treated ear
(iv) Other causes of vertigo excluded
“Certain” Deﬁnite M´ eni` ere’s disease, plus postmortem histopathologic conﬁrmation
Table 2: The point system of the Gibson score (adapted from[5, page 109]).
Parameter Description Points
Vertigo
(i) Rotational vertigo 1
(ii) Attacks of rotational vertigo lasting over 10 min 1
(iii) Rotational vertigo associated/linked with one or more of: hearing loss, tinnitus, or aural pressure 1
Hearing
(i) Sensorineural hearing loss 1
(ii) Fluctuating sensorineural hearing loss 1
(iii) Hearing loss or ﬂuctuation associated/linked with one or more of vertigo, tinnitus, or aural pressure 1
Tinnitus (i) Peripheral tinnitus lasting over 5 min 1
(ii) Tinnitus ﬂuctuating or changing with one or more of vertigo, hearing loss, or aural pressure 1
Aural pressure (i) Constant aural pressure lasting over 5 min 1
(ii) Aural pressure ﬂuctuating or changing with one or more of vertigo, hearing loss, or tinnitus 1
Maximum score 10
oftinnitusandauralfullness[11],andinitsdiagnosticpower
in detecting MD as compared with an approach based on
Prosper M´ eni` ere’s original description of the disease [10].
The Gibson score is a point system developed in 1991
by William Gibson [5]. It simpliﬁes the diagnosis of MD
through evaluating the interaction and dependence of the
four typical components present in those with MD: vertigo,
hearing, tinnitus, and aural fullness. The score is designed
to be used with the clinical history of the patient. As shown
in Table 2, each of these four components includes two (for
tinnitus and aural fullness) or three (for vertigo and hearing)
descriptionsofthesymptom.Whenadescriptionappliestoa
patient, a point is given. A total score of 7 or higher indicates
adiagnosisofMD[5].Thispointsystemisconsideredahelp-
ful clinical tool as it summarises the patient’s clinical history
with a quantiﬁcation scheme assessing the extent of the four
main MD symptoms in relation to one another. However, as
the Gibson score is obtained based on subjective assessment,
the diagnostic power of this point system also relies heavily
on the accuracy of the information used to derive the score.
The problems associated with the use of a subjective
assessment method in the diagnosis of MD arise mainly
from its reliance on the signs and symptoms nonexclusive to
the disease without a direct observation of the physiological
changes related to the aetiology of the disease. The aetiology
of MD has been linked to endolymphatic hydrops, with
evidence from histological studies [12]. Endolymphatic
hydrops refers to the swelling of the scala media from ex-
cessive accumulation of endolymph [13]. The audiometric
testing approach is not sensitive or speciﬁc enough for an
early detection of endolymphatic hydrops, which has been
considered a consistent feature of MD and thus the primary
pathology of MD [12].
Electrocochleography, which measures the auditory
evoked response (AER) from the cochlea, provides a direct
assessment of inner-ear function. An AER is an electrical
response from the auditory system elicited by an acoustic
stimulus [13], such as a click or a tone burst. With the
ECochG method, the activity of the cochlea and VIIIth cra-
nial nerve in response to acoustic stimuli can be monitoredInternational Journal of Otolaryngology 3
with an electrode either just outside, on, or through the
tympanic membrane (called extratympanic, tympanic, and
transtympanic ECochG, resp.). A ground electrode can be
placed nearby, such as on the forehead, while two electrodes
can be placed on the earlobes to obtain a diﬀerential
recording [13]. Although ECochG is more invasive than
other AERs, such as the auditory brainstem response (ABR),
it has been documented in the literature for over 30 years as a
toolforthediagnosis,assessment,andmonitoringofpatients
with MD [14].
TheECochGwaveformariseswithintheﬁrsttwoorthree
milliseconds after a rapid-onset acoustic stimulus. Originat-
ingfromthecochleaandtheeighthcranialnerve,thenormal
AERconsistsofthreecomponents:thecochlearmicrophonic
(CM), summating potential (SP), and compound action
potential (AP). Both CM and SP signals are generated by the
hair cells of the cochlea in response to an acoustic stimulus
[15, 16]. The CM potential, which is present throughout the
whole duration of an acoustic stimulus, is the extracellular
analogue of the alternating (AC) receptor current through
the outer hair cells of the cochlea [17]. The CM reﬂects the
instantaneous displacement of the basilar membrane and
hair cell stereocilia in response to an acoustic stimulus and
thus resembles a distorted version of the stimulus waveform
[15, 16, 18]. Under normal conditions, the SP arises from
the asymmetric transfer function of the inner hair cells,
and is a direct current (DC) response [13, 15]. The AP is
produced by ﬁbres within the distal (cochlear) portion of
the eighth cranial (auditory) nerve [13]. The compound
AP signal represents a collective response resulting from
numerous auditory nerve ﬁbres ﬁring synchronously [16].
The AP is usually larger than the SP, with a latency of
approximately 1.5ms [13]. Measurements commonly made
on the ECochG waveforms are the amplitudes of the SP and
AP components, using either a peak-to-trough or a baseline
reference demarcation method [15].
Endolymphatic hydrops may change the ECochG wave-
forms by increasing the magnitude of the SP in response to
clicks and tone bursts, creating an abnormally large potential
[18–20]. The eﬀect of endolymphatic hydrops on ECochG
measures has been demonstrated [21]. With endolymphatic
hydrops, the displacement of the basilar membrane towards
scala tympani moves the outer hair cell (OHC) operating
point closer to that of the inner hair cells (IHCs), resulting
in an increase of DC component in the OHC receptor cur-
rent, adding the OHC SP to the IHC SP. Furthermore, as
there are three times as many OHCs as IHCs, the SP mag-
nitude is greatly increased. In contrast, the amplitude of the
compound AP is decreased due to an OHC motor loss lead-
ing to reduced eﬃciency of the electromechanical trans-
ductionintheMETchannels.AsaiandMori[22]testedeight
patients with MD using the ECochG method and reported
that the amplitude of AP decreased with an increase of
hearing threshold at high frequencies (2–8kHz) but altered
independently of the hearing threshold at low frequencies
(0.25–1kHz)whiletheSPremainedconstantthroughoutthe
ﬂuctuation of hearing loss. An SP-to-AP ratio in response to
a click stimulus with a value greater than 40–50% has also
been shown to indicate the presence of endolymphatic hy-
drops [23]. The amplitudes of the SP and AP (measured in
microvolts) have long been used to determine if a person
hasnormalhearing,sensorineuralhearingloss,retrocochlear
hearingloss,orMD[13].Assmallchangesintheendolymph
ﬂuid of the cochlea can aﬀect the ECochG waveforms, the
ECochG appears to be sensitive to the presence of MD.
A misdiagnosis of MD will result in not only wastage and
ineﬃciency in the use of medical resources but also a trau-
matic and irreversible impact on the patient. As the AAO-
HNSCHEcriteriaapproachreliesonself-reportofthesymp-
toms, the classiﬁcation of the clinical diagnosis remains
vague and subjective. An objective, instrumental method is
needed to improve the diagnosis and management of MD.
Conlon and Gibson [20] have shown in a study of 2,964 ears
that ECochG achieved a higher level of accuracy in detecting
MD than conventional clinical examination. However, more
empirical evidence from independent studies evaluating the
diagnostic power of ECochG is needed to facilitate the clini-
cal application of ECochG as a clinical tool and enhance
the understanding of the underlying pathophysiology of
MD. This study aims to gauge the intermethod reliability in
the detection of MD between the ECochG method and two
established subjective methods, as well as comparing parti-
cipants who tested “positive” with the ECochG measures and
those who tested “negative” to explore how measurement
variability may reﬂect the underlying pathophysiology.
2. Method
2.1. Participants and Participant’s Task. Medical records,
including results from the participant’s hearing test, clinical
examination, and ECochG recordings, were retrieved from a
hospital database. The participants had been referred to the
Department of Otolaryngology at Christchurch Public Hos-
pital (Christchurch, New Zealand) in the period from year
1994 to 2009 for the diagnosis of MD, had given informed
consent to data collection for the research, and had complete
records of the results from the assessment made with the
AAO-HNS CHE criteria, Gibson score, and ECochG testing.
Ethical approvals were obtained from the New Zealand
MinistryofHealth,HealthandDisabilityEthicsCommittees,
and the University of Canterbury Ethics Committee. Based
on a quota sampling strategy, a total of 250 participants
(117 females and 133 males) were included. Ethnicity data
is routinely collected in New Zealand. Participants included
mostly individuals of European descent (94.4%), but there
were also six Asians, three M¯ aori, one Paciﬁc Islander, and
four from other ethnic groups. The age of the participants
r a n g e df r o m9t o8 8y e a r s( m e a n= 53 years, SD = 14.42).
2.2. Instrumentation. Instruments used for the recording
of ECochG signals included an electrodiagnostic system
(Amplaid MK 15, Milan, Italy), consisting of disposable elec-
trodes (Ambu Blue Sensor electrodes, Denmark), a sterilised
transtympanic (TT) needle electrode, phenol, elastic bands,
and a supra-aural headphone. The TT ECochG method,
which involves a recording needle electrode being placed
down the ear canal and through the tympanic membrane4 International Journal of Otolaryngology
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Figure 1: Instrumentation setup.
to rest on the promontory of the cochlea, was used. As
compared to the extratympanic ECochG method, which
involves an electrode resting on the tympanic membrane or
against the skin of the external auditory meatus [16, 24],
the TT ECochG method has the advantage of having the
recording electrode at a close proximity to the cochlea. This
advantage enables large ECochG response waveforms with
a minimal signal averaging required [16, 25] resulting in a
more reliable and reproducible output signal [24]. As shown
in Figure 1, the four electrodes were placed on the partici-
pant’s head, with one with an attachment to a TTneedle, one
on the forehead, and one on each of the two earlobes. The
four electrodes were connected through wires to an isolated
biological ampliﬁer, which was connected to the electrodiag-
nostic system. The supra-aural headphones (TDH39) were
also connected to the electrodiagnostic system.
2.3. Procedure. During the initial visit, a hearing test and a
clinical examination were conducted. For the hearing test, an
audiologist completed a diagnostic air conduction pure tone
audiogram using the modiﬁed Hughson-Westlake procedure
to detect the thresholds at 0.25, 0.5, 1, 2, 4, and 8kHz for
each subject bilaterally. The bone conduction threshold was
obtained at the frequencies where the air conduction thresh-
old was greater than 20dB HL to determine whether a con-
ductive or sensorineural hearing loss is present. The ECochG
recording was conducted approximately two months after
the initial clinical examination with the otolaryngologist.
ECochG Recording. For ECochG recording, the skin was
prepared with Medi-Swab alcohol skin cleansing swabs (BSN
Medical) before the ground electrode was placed on the
forehead and an active electrode attached to each two ear-
lobe.Thetympanicmembranewasanaesthetisedwithadrop
of phenol before the insertion of a sterilised TT needle elec-
trode piercing through the tympanic membrane to rest in
the round window niche. Elastic bands attached to a 6.5cm
diameter ring were positioned over the auricle of the test ear
to secure the needle in place. The participant was instructed
to lie in a supine position during testing to decrease muscle
noise while the recording took place. A headphone sound
source was located on the ring over the test ear.
The tone bursts used to elicit the ECochG AER were
at 0.5, 1, 2, and 4kHz, respectively. The intensity of the
tone bursts was 100dBnHL for the frequency at 4kHz and
90dBnHL for the frequencies at 0.5, 1, and 2kHz. The rise
and fall time speciﬁed for the tone burst was 1ms, with a
14ms plateau, a total duration of 16ms. The repetition rate
of the tone bursts was 30.1 per second. The 100µsc l i c k sw e r e
presented at an intensity of 90dBnHL, with an alternating
polarity at a rate of 10 times per second. A total of 1,024 tone
bursts per run were delivered and, along with the response
signals, recorded with an analysis time window of 30ms. A
total of 256 clicks per run were delivered and, along with
the response signals, recorded with an analysis time window
of 10ms. Both the acoustic stimuli and the AER signals
were ﬁltered respectively through a band-pass ﬁlter, which
consisted of a low-pass ﬁlter at 3kHz with a 12dB per octave
ﬁlter slope and a high-pass ﬁlter at 0.5Hz with a 6dB per
octave ﬁlter slope.
2.4. Measurements. Data retrieved from the medical records
regarding the results of the pure tone air conduction audio-
gram were hearing thresholds measured at ﬁve frequencies:
0.5, 1, 2, 4, and 8kHz. A mean threshold, termed a pure tone
average(PTA),wascalculatedforeacheartestedbyaveragingInternational Journal of Otolaryngology 5
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Figure 2: A schematic illustration of the placement of the transtympanic needle electrode and the electrocochleographic waveforms.
the thresholds measured at 0.5, 1, and 2kHz for each ear.
The components relevant to the AAO-HNS CHE criteria as
shown in Table 1 were noted by an otolaryngologist for each
participant. Any unique details of the participant’s history
were also noted, along with the type of hearing loss and
the presence of vertigo attacks, tinnitus, aural fullness, and
disequilibrium. A Gibson score was also calculated by an
otolaryngologist for each participant. The scoring was based
on the standard point system as shown in Table 2.M e a s u r e -
ments from the ECochG signals recorded for each partic-
ipant included measures derived from signals in response
to tone bursts and clicks, respectively. The SP amplitude
(in µV), AP amplitude (in µV), and an SP-to-AP ampli-
tude ratio (in %) were obtained for each ear for tone
bursts generated at 0.5, 1, 2, and 4kHz, respectively, and
for clicks. Figure 2 illustrates the measures derived from the
ECochGwaveformsaswellastheplacementoftheTTneedle
electrode used to obtain the ECochG signals.
2.5. Data Analysis. The participant’s basic demographic
information, including name, date of birth, sex, and identity
number, and the speciﬁc test results for auditory thresholds,
Gibson score, ECochG measurement, and components re-
lated to the AAO-HNS CHE criteria were extracted from the
medicalrecordsforeachparticipant.Basedonthesymptoms
indicated on the participant’s medical records, the 1995
AAO-HNSCHEcriteriaaspreviouslydescribed(see Table 1)
were used to determine whether a participant would be clas-
siﬁed as having “possible,” “probable,” or “deﬁnite” MD.
EachGibsonscorewasobtainedbasedonthescoresrecorded
for the components included in the point system [26]. Based
on the ECochG measures, participants with any recorded SP
values for clicks or tone bursts greater than the normative
data values, as speciﬁed in Table 3 [27], were classiﬁed as
“positive” and those with none of the recorded SP values
greater than the normative data values as “negative.”
2.6. Statistical Analysis. Measures yielded by the three diag-
nostic tools, including ECochG, AAO-HNS CHE, and Gib-
son score, were compared. With the ECochG diagnostic test
Table 3: Electrocochleography criteria [27]. The diagnostic level
was chosen as the nearest whole ﬁgure to the level which provides
a false-positive diagnosis rate of 5%. The likelihood of hydrops is a
Gibson score of >7/10 [6]. Clicks: abnormal if SP/AP ratio ≥0.50.
Tone bursts
Tone burst frequency Hearing level dBHL Abnormal if SP ≤
0.5kHz (75 dBHL)
Under 25 −2 µV
20–35 −2 µV
40–55 −2 µV
60–75 −1 µV
1kHz(90dBHL)
Under 25 −6 µV
20–35 −6 µV
40–55 −6 µV
60–75 −3 µV
2kHz (100 dBHL)
Under 25 −9 µV
20–35 −7 µV
40–55 −5 µV
60–75 −5 µV
4kHz(75dBHL)
Under 25 −9 µV
20–35 −5 µV
40–55 −5 µV
60–75 −5 µV
taken as the hypothetical “gold standard,” the sensitivity
and speciﬁcity of the two subjective tests, including AAO-
HNS CHE criteria and Gibson score, were calculated (see
Table 4). An ROC curve was plotted for both subjective
tests. The best cutoﬀ point for each of the two ROC curves
was chosen to assess intermethod reliability. To determine
the level of agreement between the three diagnostic tools,
four types of intermethod reliability, including total, point-
by-point, occurrence, and nonoccurrence reliability, were
calculated based on the formula as shown in Table 5.W i t h
“positive” and “negative” identiﬁcations made through the
three diagnostic tools respectively, a series of chi-square tests
were conducted to compare the number of participants in6 International Journal of Otolaryngology
Table 4: Formula for calculating the diagnostic power of the two
subjective tests, respectively, as compared with the diagnosis based
on ECochG measures.
ECochG diagnosis
(hypothetical “gold standard”)
Positive Negative
Results from
AAO-HNS CHE
(or Gibson score)
Positive a
(true positive)
b
(false positive)
Negative c
(false negative)
d
(true negative)
Sensitivity = a/(a+c).
Speciﬁcity = d/(b+d).
Positive predictive value = a/(a+b).
Negative predictive value = d/(c+d).
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Figure 3: A receiver operating characteristic (ROC) curve of the
Gibson score test showing 11 cutoﬀ points (right to left from 0 to
10) and that of the AAO-HNS CHE test showing 3 cutoﬀ points
(“possible,” “probable,” and “deﬁnite”).
groups related to diﬀerent classiﬁcations. A series of cor-
relation procedures were also conducted to determine the re-
lationships between a selection of ECochG measures in the
“positive” and “negative” groups, respectively. The signiﬁ-
cance level was set at 0.1, with adjustments using the Bonfer-
roni correction for multiple testing.
3. Results
The ROC curves for the two subjective tests, with the
ECochG diagnosis taken as the hypothetical “gold standard,”
were plotted in Figure 3.T h r e ec u t o ﬀ points (“possible,”
“probable,” and “deﬁnite”) were marked on the ROC curve
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Figure 4: Percentage of participants identiﬁed as “positive” and
“negative,” respectively, using diﬀerent diagnostic methods, includ-
ing ECochG method, AAO-HNS CHE criteria with only “deﬁnite”
beingclassiﬁedas“positive”(AAO-1),AAO-HNSCHEcriteriawith
both “deﬁnite” and “probable” being classiﬁed as “positive” (AAO-
2), and Gibson score with 7 as the cutoﬀ point.
for the AAO-HNS CHE criteria and eleven cutoﬀ points
(from 0 to 10 in steps of one) on that for the Gibson score.
The area under the curve for the Gibson score was found to
be signiﬁcantly greater than that for the AAO-HNS CHE cri-
teria (chi-square = 22.51, df = 1, p<0.001), indicating that
the Gibson score was more powerful in discriminating be-
tween “positive” and “negative” ECochG cases. The ROC
curvefortheGibsonscoreappearstohaveasharpturnatthe
cutoﬀ point of seven, which falls on the cutoﬀ value recom-
mended by Gibson [27] to make a positive MD diagnosis.
The shape of the ROC curve for the Gibson score is typical
of an ROC curve constructed when a real “gold standard” di-
agnosis is available for comparison, suggesting that the
ECochG method provides a valid alternative to the two sub-
jective methods.
Figure 4showsthepercentageofparticipantsinthe“pos-
itive ” and “negative” groups as classiﬁed with diﬀerent diag-
nostic methods. The AAO-HNS CHE criteria were changed
to a dichotomous classiﬁcation in two ways, one with
“deﬁnite” and “probable” identiﬁed as “positive” (“AAO-def-
inite/probable”) and the other with only “deﬁnite” identiﬁed
as “positive” (“AAO-deﬁnite”). The Gibson score with a cut-
oﬀpoint of7wasusedformaking thediagnosis. Asshownin
Figure 4,bothECochGandAAO-HNSCHEmethodsidenti-
ﬁed more positive cases than negative cases while the ap-
proach with the Gibson score identiﬁed more negative cases
than positive cases. Figure 5 illustrates results for a series
of intermethod reliability measures between ECochG and
AAO-HNSCHEcriteria,betweenECochGandGibsonscore,
and between AAO-HNS CHE criteria and Gibson score.
As shown in Figure 5, the point-by-point, occurrence, and
nonoccurrence reliability were highest between AAO-HNS
CHE criteria and Gibson score and the total reliabilityInternational Journal of Otolaryngology 7
Table 5: Conditions given for the calculation of four types of intermethod reliability (formula: reliability = (a/b) × 100).
Reliability Conditions
Total a = the smaller frequency of “positive” identiﬁcation by one test
b = the larger frequency of “positive” identiﬁcation by the other test
Point by point a = the number of cases with the same identiﬁcation from both tests
b = the total number of cases
Occurrence a = the number of cases who tested “positive” in both tests
b = the number of cases who tested “positive” at least in one test
Nonoccurrence a = the number of cases who tested “negative” in both tests
b = the number of cases who tested “negative” at least in one test
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Figure 5: Total, point-by-point, occurrence, and nonoccurrence
reliability between ECochG method and AAO-HNS CHE criteria,
between ECochG method and Gibson score, and between AAO-
HNS CHE criteria and Gibson score.
was highest between ECochG and AAO-HNS CHE criteria.
There were a greater proportion of males (66%) identiﬁed
as “positive” ECochG than females (43%). Based on the
AAO-HNS CHE criteria, the majority of the participants
diagnosed as “deﬁnite MD” were between 51–60 years
(18.8%), those as “probable MD” were between 41 and 50
years (1.34%), and those as “possible MD” were between
51 and 60 years (6.71%). The majority of the participants
whotested“positive”forMDwithECochGwerebetweenthe
ages of 41 and 80 years of age (87.24%). For the “positive”
ECochG cases, a signiﬁcantly higher amount of participants
had unilateral (left ear: 36.9%; right ear: 45%) than bilateral
MD (18.1%). Furthermore, more bilateral MD cases were
identiﬁed using the ECochG method (27 cases) as compared
with the Gibson score (1 case). A comparison of the tone
burst and click ECochG results for the total number of
participants who tested as “positive” with ECochG revealed
thatthetoneburstmethod(59.5%)generallyidentiﬁedmore
“positive”casesthantheclickmethod(24.8%).TheECoChG
classiﬁcation results based on the composite click and tone
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Figure 6: Percentage of patients showing each of the four key
symptoms of MD.
criteria as shown in Table 3 were found to be most highly
correlated with the results obtained based on measures with
tone bursts at 1kHz alone (r = 0.79), followed in order
by those with tone bursts at 2kHz alone (r = 0.62), tone
bursts at 0.5kHz alone (r = 0.45), tone bursts at 4kHz alone
(r = 0.43), and clicks alone (r = 0.42).
3.1. Distributions of MD Symptoms. Figure 6 shows a com-
parison between “positive” and “negative” ECochG cases
on the prevalence of the four key MD symptoms, namely,
hearing loss, vertigo, tinnitus, and feeling of aural fullness.
As shown in Figure 6, participants whotested “positive” with
ECochGexhibitedahigheroccurrencerateofthefoursymp-
toms than those who tested “negative.” Both hearing loss
and vertigo were the most prevalent symptoms, followed in
order by tinnitus and feeling of aural fullness (see Figure 6).
No signiﬁcant diﬀerence on the occurrence rate was found
between hearing loss and vertigo (“positive” ECochG: chi-
square = 0.098, df = 1, p = 0.75; “negative” ECochG: chi-
square = 0.615, df = 1, p = 0.43). A signiﬁcant diﬀerence
on the occurrence rate was found for all the other pairwise8 International Journal of Otolaryngology
comparisons,includingthecomparisonbetweenhearingloss
and tinnitus (“positive” ECochG: chi-square = 44.5, df = 1,
p<0.001; “negative” ECochG: chi-square = 8.621, df =
1, p = 0.003), hearing loss and aural fullness (“positive”
ECochG: chi-square = 74.37, df = 1, p<0.001; “negative”
ECochG: chi-square = 51.65, df = 1, p<0.001), vertigo
and tinnitus (“positive” ECochG: chi-square = 7.645, df = 1,
p = 0.006; “negative” ECochG: chi-square = 14.73, df = 1,
p<0.001), vertigo and aural fullness (“positive” ECochG:
chi-square = 23.69, df = 1, p<0.001; “negative” ECochG:
chi-square = 63.88, df = 1, p<0.001), and tinnitus and
aural fullness (“positive” ECochG: chi-square = 6.07, df = 1,
p = 0.014; “negative” ECochG: chi-square = 18.79, df = 1,
p<0.001).
3.2.HearingLossPatterns. RegardlessoftheECochGdiagno-
sis, there was generally a higher proportion of asymmetrical
hearing thresholds (“positive” ECochG: 88.7%; “negative”
ECochG: 72.5%) than symmetrical hearing thresholds. The
“positive” ECochG group was found to have a signiﬁcantly
higher proportion of participants showing asymmetrical
hearing thresholds than the “negative” ECochG group (chi-
square = 9.66, df = 1, p = 0.002). While the occurrence
rates across the three types of between-ear contrast were not
signiﬁcantly diﬀerent in the “negative” ECochG group (chi-
square = 2.51, df = 2, p = 0.286), they were signiﬁcantly
diﬀerentinthe“positive”ECochGgroup(chi-square=46.15,
df = 2, p<0.001), with a signiﬁcantly higher occurrence rate
of asymmetrical threshold (“left ear poorer”: 43.3%; “right
earpoorer”:45.4%)ascomparedwithsymmetricalthreshold
shift (11.3%), whether the poorer threshold was found in the
left ear (chi-square = 34.59, df = 1, p<0.001) or the right ear
(chi-square = 38.548, df = 1, p<0.001). For the “positive”
ECochG group, the occurrence rates for the “left ear to be
the poorer ear” or “right ear to be the poorer ear” were
not signiﬁcantly diﬀerent (chi-square = 0.058, df = 1, p =
0.811). As for the level of between-ear threshold diﬀerence, a
comparison between the “positive” and “negative” ECochG
groups on the proportions of participants with low (0–15dB
HL) and high (equal or greater than 20dB HL) between-
ear threshold diﬀerences revealed that a signiﬁcantly higher
proportion (60.3%) of “positive” ECochG cases exhibited a
“high” between-ear threshold diﬀerence (chi-square = 11.12,
df = 1, p<0.001) while a signiﬁcantly lower proportion
(18.3%) of “negative” cases showed a “high” between-ear
threshold diﬀerence (chi-square = 84.84, df = 1, p<0.001).
Figure 7 shows the average hearing thresholds at 0.5, 1, 2,
and 4kHz for the “positive” and “negative” ECochG groups,
respectively. An inspection of Figure 7 revealed that the “ne-
gative” ECochG group had a lower average hearing thre-
shold at all frequencies than the “positive” ECochG group,
with the highest hearing threshold being at 4kHz for both
“positive” and “negative” ECochG groups.
3.3. Relationships between ECochG Measures. Table 6 shows
the results from a series of Pearson’s Product Moment corre-
lation procedures conducted to determine the relationships
betweentheSP/APratiosobtainedfromadjacentfrequencies
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Figure 7: Means and standard deviations of the hearing thresholds
as measured at 0.5, 1, 2, and 4kHz for the “positive” and “negative”
ECochG groups.
in the “positive” and “negative” groups as classiﬁed by the
three diagnostic methods, respectively. With the ECochG di-
agnosis, SP/AP ratios measured at adjacent frequencies (i.e,
0.5 versus 1kHz, 1 versus 2kHz, and 2 versus 4kHz) were
moderately or highly correlated more often in the “positive”
group than in the “negative” group. To further explore
the interfrequency variation on the SP/AP measure, the
coeﬃcient of variation (COV) of the mean and standard
deviation of the SP/AP ratios extracted from the four
frequencies was obtained for each ear. The COV was deﬁned
as 100 times the ratio of standard deviation to mean. The
value from the ear with a higher COV was selected for
each participant for statistical analysis. Results from a two-
way (2 diagnostic groups X 3 diagnostic methods) analysis
of variance conducted on the COV measures revealed no
signiﬁcant method eﬀect (F (2, 726) = 0.236, p = 0.79) but
a signiﬁcant diagnostic group eﬀect (F (1, 726) = 26.244,
p<0.001) and a signiﬁcant method by group interaction
eﬀect (F (2, 726) = 5.063, p = 0.007). Post hoc pairwise
comparison tests revealed that the COV in the “positive”
group (mean = 79.7) was signiﬁcantly lower than that in the
“negative” groups (mean = 115.4) only when the classiﬁca-
tion was based on the ECochG method.
4. Discussion
The purpose of this study was to evaluate how ECochG may
function as a diagnostic tool for MD as compared with the
conventional subjective methods. Both ECochG and AAO-
HNS CHE criteria were found to independently diagnose
a similar amount of participants with MD. The point-by-
point intermethod reliability was found to be moderate
among the three diagnostic methods. In the literature, the
ECochG method has been found to be more speciﬁc but not
adequately sensitive (20–65%) for the diagnosis of MD if the
diagnosis was made based on cutoﬀ values [14]. It has beenInternational Journal of Otolaryngology 9
Table 6: Correlations (Pearson’s r) between SP/AP ratios obtained at 0.5, 1, 2, and 4kHz in the “positive” (POS) and “negative” (NEG) cases
classiﬁed by three diagnostic methods.
0.5kHz 1kHz 2kHz
POS NEG POS NEG POS NEG
ECochG:
1kHz R 0.49 0.20
L 0.52 0.44
2kHz R 0.37 0.22 0.70 0.63
L 0.37 0.38 0.72 0.47
4kHz R 0.26 0.19 0.42 0.21 0.48 0.31
L 0.22 0.23 0.35 0.51 0.53 0.34
AAO-HNS CHE (“possible” as negative):
1kHz R 0.50 0.43
L 0.61 0.50
2kHz R 0.42 0.36 0.74 0.75
L0 . 4 50.51 0.71 0.69
4kHz R 0.39 0.17 0.43 0.48 0.46 0.57
L 0.21 0.41 0.29 0.65 0.52 0.47
Gibson score (cutoﬀ point at 7):
1kHz R 0.51 0.41
L 0.60 0.51
2kHz R 0.46 0.31 0.78 0.70
L0 . 4 10.50 0.70 0.69
4kHz R 0.42 0.16 0.43 0.46 0.47 0.54
L 0.17 0.43 0.22 0.64 0.44 0.55
∗Signiﬁcant correlations with a coeﬃcient above 0.5 were in boldface.
shown, however, that the sensitivity of the ECochG test can
be greatly improved (92%) if the amplitude and duration of
the SP and AP are taken into consideration for setting the
diagnostic criteria [14]. Therefore, the use of cutoﬀ scores
to obtain a diagnosis in this study may have contributed to
someofthediagnosticdisagreementwiththeothertwodiag-
nostic tools. The present ﬁnding that participants who tested
“positive,” regardless of the diagnostic method used, showed
a greater correspondence between the SP/AP ratios at adja-
cent frequencies (i.e., 0.5 versus 1kHz, 1 versus 2kHz, and 2
versus 4kHz) than those who tested “negative” suggests that
the correlations between these ECochG measures at adjacent
frequencies may be useful for diﬀerentiating the impact of
endolymphatic hydrops on the auditory system from that
of other pathologies. In other words, the ECochG method
may be more sensitive to the presence of MD if applied with
a better discriminating rule, such as one that reﬂects the
consistency of the measures between adjacent frequencies.
Another source of disagreement between the ECochG
method and the other two subjective methods may be
related to the ﬂuctuating nature of the MD symptoms. In
the early stage of MD, in particular, if the ECochG test is
administered when no symptoms are present, it is unlikely
that a positive diagnosis will be made. Due to the time it
takes for an appointment which includes a hearing test, it
is not practical to assess a person with ECochG at an initial
consultation and there may be a long hospital waiting list for
the test to be done. It is normally considered costly, time
ineﬃcient, and impractical for the participant, physician,
and audiologist to repeat the ECochG test until a participant
is fully symptomatic of MD. As a result, the participant may
be in tremendous discomfort for years if they are waiting on
a positive ECochG result. As the AAO-HNS-CHE criterion is
a subjective diagnostic tool, the application of the criteria is
susceptible to rating inconsistency. In addition to providing
an objective and physiological measure of the pathology, the
ECochGmethod,whichassesseseachearindependently,also
has the advantage of taking unilateral and bilateral MD into
diagnostic consideration. The high agreement between the
ECochG method and the two subjective assessment methods
suggests that ECochG used in combination with another
assessment tool for the diagnosis of MD, such as the AAO-
HNS CHE criteria or the Gibson score, would be beneﬁcial.
Therefore, repeated measures at diﬀerent points of time
or administering the ECochG test around the time when
symptoms occur would be useful for enhancing the power
of the ECochG method as a diagnostic tool.
Ithasbeennotedthatclicksevokeaclearactionpotential
due to their sharp onset but can cause acoustic ringing and
distort the SP unpredictably. In contrast, tone bursts have a
longer duration, which enhances the diﬀerentiation between
SP and AP [28]. In an ECochG study of 42 normal ears, 48
ears with sensorineural hearing loss, and 80 M´ eni` ere’s ears,
the 1kHz tone burst was shown to result in a higher accuracy
levelthantheclickinassistingintheclinicaldiagnosisofMD
[28]. Likewise, tone bursts were found in an ECochG study10 International Journal of Otolaryngology
of 2,421 ears to have the advantage over clicks in showing
better frequency selectivity for monitoring the degree of
endolymphatic hydrops at speciﬁc turns of the cochlea [25].
The present ﬁnding that the tone burst ECochG method
yieldedmore“positive”ECochGcasesthantheclickECochG
method agrees with the previous observation that a tone
burst, especially at 1kHz, is more sensitive than a click in
eliciting AER for the diagnosis of MD.
There was a common observation in the literature that
MD typically occurred unilaterally rather than bilaterally
[29], with a reported estimate that bilateral MD occurred in
one in three participants [30]. As bilateral MD is considered
a natural progression for the disease in some people, it is
of importance that every attempt at conservation of the
nonsymptomatic ear should be made as early as possible. In
addition, almost all participants with a “positive” ECochG
diagnosis were found in this study to exhibit hearing loss
and vertigo and to a lesser extent, tinnitus and aural fullness.
Clinical guidelines suggest that a participant with a 20dB
HL or greater diﬀerence between audiometric thresholds
s h o u l db er e f e r r e dt oa no t o l a r y n g o l o g i s tf o re v a l u a t i o no f
asymmetrical hearing thresholds. As many of the majority of
participants with a large threshold diﬀerence between ears in
this study were found to show a positive ECochG result and
a “deﬁnite MD” AAO-HNS CHE diagnosis, asymmetrical
hearing threshold, along with positive ECohG, may be a
dominant early sign of MD.
The onset of MD is usually said to be around the fourth
or ﬁfth decade of life [4, 31]. In this study, most of the
participants identiﬁed as “deﬁnite MD” are between the ages
of 41 and 80, making this sample a much older population
of MD patients. In addition, the present study showed that
more males had MD than females. As the literature does
not indicate that MD is more common in males [32], more
investigations are needed regarding the gender diﬀerence in
the prevalence of MD. Future studies extending to other
regions, as well as involving the analysis of the progression
of hearing loss in the MD participants, are needed.
5. Conclusions
T h eE C o c h Gm e t h o dw a sf o u n dt ob ei nb e t t e ra g r e e m e n t
with the Gibson score than other diagnostic measures. The
ﬁnding that there were still some disagreements among the
three assessment methods in the diagnosis of MD suggested
that a diagnosis of MD should not be made with a single di-
agnostic tool in their present forms of application. As there
was some evidence suggesting that the signs of MD may be
distinguishablefromthoseofothercausesbasedontheinter-
frequency relationship between ECochG measures obtained
at adjacent frequencies, the consistency between ECochG
measures across adjacent frequencies needs further investi-
gation.
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